Anti-Cancer Drugs Journal Issues Research Articles in July 2022 Edition
June 09, 2022
June 09, 2022
LONDON, England, June 9 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles, including the following topics, in its July 2022 edition:
Pre-Clinical Report:
* In-silico drug-likeness analysis, ADME properties, and molecular docking stu . . .
Pre-Clinical Report:
* In-silico drug-likeness analysis, ADME properties, and molecular docking stu . . .